Home »
Academic Articles & Research Papers
Showing 7 of 7 academic articles
Süwer S, Bagemihl K, Baier S, Dicunta L et al. • JMIR AI
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.2196/93862
PMC: PMC13730514
Jain A, Rosell R, Dharmashekara C, Shreevatsa B et al. • Naunyn-Schmiedeberg's archives of pharmacology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s00210-026-05533-0
PMC: PMC13593669
Man Luo, Man Luo, Man Luo, Jiang Zhu et al. • Frontiers in Pharmacology
(2025)
BackgroundDrug repurposing has emerged as a promising approach for discovering novel anticancer therapeutics. In this study, we systematically investigated the antitumor potential of fedratinib, a JAK2 inhibitor approved for myelofibrosis, ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fphar.2025.1689663
Matthew Lynch, Sophie Manoy, Peter D. Sly, Claire E. Wainwright et al. • EBioMedicine
(2025)
Summary: Background: Ataxia-telangiectasia (A-T) is a rare multisystem disease characterised by neurodegenerative cerebellar ataxia, lung disease, immune deficiency, high cancer risk, and mitochondrial dysfunction. A-T cells demonstrate de...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.ebiom.2025.105840
Claudio Tomi-Andrino, Alina Pandele, Klaus Winzer, John King et al. • Scientific Reports
(2022)
Abstract The manifestation of intra- and inter-tumor heterogeneity hinders the development of ubiquitous cancer treatments, thus requiring a tailored therapy for each cancer type. Specifically, the reprogramming of cellular metabolism has b...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-022-14721-w
Jörn Lötsch, Alfred Ultsch • Pain
(2017)
1. Introduction Pain and pain chronification are incompletely understood and unresolved medical problems that continue to have a high prevalence.14 It has been accepted that pain is a complex phenomenon.2,32,72 Contemporary methods of compu...
OPENALEX
cc-by-nc-nd
DOI: https://doi.org/10.1097/j.pain.0000000000001118
PMC: 5895117
Kai Zhao, Yujia Shi, Hon-Cheong So • Pharmaceutics
(2022)
Identification of the correct targets is a key element for successful drug development. However, there are limited approaches for predicting drug targets for specific diseases using omics data, and few have leveraged expression profiles fro...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics14020234